Missiles cost millions. Drones cost thousands. That math does not work anymore. As cheap aerial threats overwhelm traditional defenses, militaries are turning to lasers that can destroy targets for ...

Meta's work made headlines and raised a possibility once considered pure fantasy: that AI could soon outperform the world's best mathematicians by cracking math's marquee "unsolvable" problems en ...

Subscribe or Fortnite Kid will crank 90s on you! Hey there! I'm Hew Moran, a content creator who combines my passion for ...

For the past several years, America has been using its young people as lab rats in a sweeping, if not exactly thought-out, education experiment. Schools across the country have been lowering standards ...

Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

There were six violations of a restricted airspace over Bedminster, New Jersey, while President Donald Trump was staying at his residence there over the weekend, the U.S. Air Force said. One of those ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...

Alongside the withdrawal request, the FDA has also placed a clinical hold on all Intercept clinical trials involving obeticholic acid. Intercept Pharmaceuticals has decided to voluntarily withdraw ...